ScoreWhy is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. ?
1
Flat results in Mar 26
- INTEREST(HY) At CNY 67.84 MM has Grown at 87.13%
- DEBT-EQUITY RATIO (HY) Highest at -4.46 %
2
With ROE of 16.22%, it has a attractive valuation with a 1.72 Price to Book Value
- Over the past year, while the stock has generated a return of -24.49%, its profits have risen by 3.4%
- At the current price, the company has a high dividend yield of 2.6
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -24.49% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
-22.96%
-2.32
16.64%
China Shanghai Composite
23.91%
1.73
13.79%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
17.66%
EBIT Growth (5y)
17.08%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.08
Tax Ratio
17.88%
Dividend Payout Ratio
50.49%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.37%
ROE (avg)
15.25%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
1.72
EV to EBIT
9.24
EV to EBITDA
7.29
EV to Capital Employed
1.76
EV to Sales
1.18
PEG Ratio
NA
Dividend Yield
2.57%
ROCE (Latest)
19.04%
ROE (Latest)
16.22%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 5,674.91 MM
NET SALES(HY)
At CNY 17,746.01 MM has Grown at 21.12%
RAW MATERIAL COST(Y)
Fallen by -13.54% (YoY
-9What is not working for the Company
INTEREST(HY)
At CNY 67.84 MM has Grown at 87.13%
DEBT-EQUITY RATIO
(HY)
Highest at -4.46 %
Here's what is working for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Net Sales
At CNY 17,746.01 MM has Grown at 21.12%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Cash Flow
Highest at CNY 5,674.91 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -13.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Interest
At CNY 67.84 MM has Grown at 87.13%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debt-Equity Ratio
Highest at -4.46 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
